English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduA new study offers a first look into the complex molecular changes that occur in brain cells with Lewy bodies, which are key pathological hallmarks of Parkinson’s disease and some dementias.
Tag: Lewy Body Dementia
Lewy body disease can be detected before symptoms
Lewy body disease is the second most common neurodegenerative disease after Alzheimer’s disease. A research group from Lund University has now shown that the disease can be detected before symptoms appear, using a spinal fluid test.
New blood test can detect ‘toxic’ protein years before Alzheimer’s symptoms emerge, study shows
Researchers can detect small “toxic” aggregates of a particular protein in the blood of individuals with Alzheimer’s disease and in individuals who showed no signs of cognitive impairment at the time the blood sample was taken, but who developed it at a later date.
Will reduction in tau protein protect against Parkinson’s and Lewy body dementias?
A study suggests that reducing tau protein in brain neurons will not protect against Parkinson’s disease and Lewy body dementias. If borne out, this result differs from Alzheimer’s disease, where reducing endogenous tau levels in brain neurons is protective for multiple models of the disease.
Lewy Body Dementia: Q&A with Michele Tagliati, MD
Lewy body dementia, also known as dementia with Lewy bodies, is a relatively frequent but often misunderstood form of dementia, which can cause loss of memory, language and problem-solving ability.
Alzheimer’s book offers updated resource for patients, care partners
Misplacing keys, forgetting the way to a doctor’s appointment, trouble recalling a neighbor’s name: Are these examples of typical aging? What’s the difference between Alzheimer’s disease and other forms of dementia? What’s actually happening to the brain, and how can you keep it healthy?
$5.5 million NIH grant supports new tests to diagnose dementias earlier and easier
Researchers at Case Western Reserve University School of Medicine seek to optimize emerging methods of diagnosing two common neurodegenerative diseases—dementia with Lewy bodies and Parkinson’s disease dementia—which affect 1.4 million in the United States
FAU Medicine Ushers in New Research Phase to Prevent Dementia
FAU’s Schmidt College of Medicine and The Harry T. Mangurian, Jr. Foundation have joined forces again to usher in a new phase of research to prevent dementia. The extension of a three-year, $3 million grant from the foundation will launch the new FAU Center for Brain Health. The grant supports precision medicine approaches to prevent dementia, which will be further strengthened by leveraging multiple patient-centered platforms through state-of-the-art transdisciplinary approaches.